Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Our aim is to observe whether anti-TNF-alpha regimen will effect serum adiponectin
concentration after myocardial infarction/reperfusion and also beneficial for the patients
undergoing percutaneous coronary intervention (PCI).